News & Events

Press Releases

On the 28th March 2022, OncoArendi changed its name to Molecure

OncoArendi continues to grow by executing further steps of the strategy and initiates two new drug discovery programs within its existing research platforms

19 August 2021

Galapagos informed about the initiation of a clinical trial to evaluate potential pharmacokinetic interactions of GLPG4716

21 July 2021

OncoArendi executes the strategy for 2021-2025 in the area of R&D platform for developing small molecules modulating RNA function

16 June 2021

OncoArendi and Galapagos enter into exclusive collaboration on chitinase inhibitors in fibrosis

5 November 2020

American Journal of Medicinal Chemistry distinguishes OncoArendi publication on OATD-01

21 October 2020

OncoArendi Therapeutics expands the therapeutic potential of its Chitinase Platform

13 October 2020

Sign up for the latest News & Events

Events & Presentations

Fibrosis and Tissue Repair: From Molecules and Mechanics to Therapeutic Approaches – February 19-23, 2020 | Victoria, BC, Canada

27 February 2020

EFMC-ASMC’19 – September 1-5, 2019 | Athens, Greece

11 September 2019

ACS National Meeting & Expo – August 25 – 29, 2019 | San Diego, CA

4 September 2019

ATS- International Conference – Dallas, 17-22.05.2019

22 May 2019

EFMC – YMCS – Young Medicinal Chemist Symposium – Ljubljana 02-06.09.2018

17 September 2018

EFMC – International Symposium on Medicinal Chemistry – Ljubljana 02-06.09.2018

17 September 2018
This site is registered on wpml.org as a development site.